Product How it works Pricing Blog FAQ About Contact
Ramsay Générale de Santé

Ramsay Générale de Santé (EPA: GDS) financial statements

The consolidated income statement, balance sheet and cash flow statement of Ramsay Générale de Santé for its last 6 fiscal years, as filed with the regulator, in millions of euros. At the end of fiscal 2025 it had €6,682m in total assets and €1,121m in equity.

Income statement

Item202520242023202220212020
Revenue€5,381m€5,242m€5,007m€4,702m€4,301m€4,023m
Operating profit€186.3m€173.2m€160.6m€240.4m€291.3m€250.6m
Income tax€19.5m€1.6m−€4.1m€23.8m€57.3m€29.5m
Net profit−€48.3m−€54.1m−€53.9m€49.4m€118.4m€65.0m
Earnings per share−€0.44−€0.49−€0.49€0.45€1.07€0.59
Diluted earnings per share−€0.44−€0.49−€0.49€0.45€1.07€0.59
Depreciation and amortisation€440.8m€434.0m€426.7m€403.2m€377.3m€371.8m

Balance sheet

Item202520242023202220212020
Total assets€6,682m€6,839m€6,895m€6,958m€6,788m€6,682m
Current assets——€1,467m€1,366m€1,255m€1,469m
Inventories€131.3m€125.1m€125.0m€118.2m€111.2m€111.4m
Property, plant and equipment€931.2m€936.0m€974.4m€991.2m€950.2m€918.0m
Goodwill€2,063m€2,088m€2,081m€2,063m€2,065m€1,763m
Cash€302.2m€366.5m€359.0m€352.2m€132.5m€608.4m
Current liabilities——€1,686m€1,493m€1,485m€1,551m
Equity€1,121m€1,145m€1,194m€1,246m€1,212m€1,070m
Equity including minorities€1,156m€1,182m€1,230m€1,277m€1,239m€1,099m
Minority interests€35.1m€36.6m€35.4m€31.0m€26.3m€28.4m

Cash flow statement

Item202520242023202220212020
Operating cash flow€524.7m€693.7m€586.8m€598.9m€262.5m€652.3m
Investing cash flow−€132.9m−€138.4m−€180.5m−€175.4m−€471.1m−€181.4m
Financing cash flow−€454.0m−€550.2m−€401.5m−€197.1m−€264.2m−€390.6m

Where each figure comes from

From the annual report Ramsay Générale de Santé files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Ramsay Générale de Santé page.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.